Home Your basket
• CT scanning in "second lo...
   Price 5.50 €
• The rehabilitation of the...
   Price 10.50 €
• Peptide receptor radionuc...
   Price 14.00 €
• Neuroplasticity in the au...
   Price 10.50 €
• Cholesteatoma presenting ...
   Price 12.50 €
• Focus on the BPPV: Semont...
   Price 12.50 €
• Long term results of tymp...
   Price 5.50 €
• Epitympanic osteoma of th...
   Price 12.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Speech disorders, verbal ...
   Price 10.50 €
• Giant osteoma of the maxi...
   Price 8.50 €
• Transoral surgical treatm...
   Price 8.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Congenital anomalies of n...
   Price 14.00 €
• Transit time of swallowin...
   Price 10.50 €
• Total ossicular reconstru...
   Price 10.50 €
• Non-Hodgkin's lymphoma of...
   Price 5.50 €
• Detection and role of hum...
   Price 14.00 €
• Dehiscence of the superio...
   Price 10.50 €
• Treatment of children wit...
   Price 8.50 €
• Videonystagmography and v...
   Price 10.50 €
• The Voice Handicap Index:...
   Price 10.50 €
• A non-linear model of lar...
   Price 10.50 €
• Results of six years expe...
   Price 8.50 €
• Malignant melanoma of the...
   Price 10.50 €
• Viral assumption and inve...
   Price 10.50 €
• Mandibular reconstruction...
   Price 8.50 €
• Endoscopic-assisted retro...
   Price 10.50 €
• Respiratory epithelial ad...
   Price 12.50 €
• What is the effect of diz...
   Price 10.50 €
• A perceptual study of the...
   Price 8.50 €
• Desmoplastic ameloblastom...
   Price 5.50 €
• Cochlear implantation in ...
   Price 5.50 €
• Clinical signs and correl...
   Price 10.50 €
• Life after total laryngec...
   Price 8.50 €
• Decompression surgery for...
   Price 8.50 €
• Pleomorphic adenoma of th...
   Price 12.00 €
• A histopathologic evaluat...
   Price 8.50 €

Total Order 369.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2007 o

RHINOLOGY

Efficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitis


Authors : Klossek J. M (Poitiers)

Ref. : Rev Laryngol Otol Rhinol. 2007;128,3:187-192.

Article published in french
Downloadable PDF document french



Summary : Sinusitis or acute rhinosinusitis, is defined as an acute viral or bacterial infection characterised by inflammation of the mucosa of the nose and paranasal sinuses. Although antibiotics are routinely prescribed for the treatment of acute sinusitis, most cases are caused by viral infections and will resolve without antibiotic therapy. Given concerns about global antibacterial resistance, evidence-based clinical practice guidelines recommend a conservative approach to antibiotic treatment, with mild or moderately severe acute sinusitis managed symptomatically. Intranasal corticosteroids act on the nasal mucosa to relieve inflammation and its associated symptoms, and may be a useful symptomatic treatment option. Two randomised, placebo-controlled trials have demonstrated that the corticosteroid mometasone furoate, administered as a nasal spray (MFNS), is effective as an adjunct to antibiotics in acute sinusitis. The design of these studies show a therapeutic approach known in Europe, but this attitude is still different from the current French guidelines. Furthermore, the efficacy and safety of MFNS monotherapy has been compared with antibiotic therapy in a randomised, double-blind, placebo-controlled trial in adults with acute uncomplicated sinusitis and probably viral. In this study, twice-daily (BID) MFNS 200 µg produced statistically greater improvements in overall symptoms and most individual symptoms compared with amoxicillin or placebo, even though Amoxicillin is not the one recommended by the French guidelines for this indication. These findings suggest that MFNS may play an important role in the management of acute sinusitis, either as monotherapy or as adjunctive treatment to antibiotics. These results lead also to think over its interest in the treatment of uncomplicated common forms of sinusitis, where antibiotics are still widely prescribed in daily practice.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE